Virax Biolabs Group LtdVRAX
Virax Biolabs Group Ltd — a healthcare name on Nasdaq.
Virax Biolabs Group Ltd (VRAX) belongs to the healthcare sector, listed on Nasdaq operating in in vitro & in vivo diagnostic substances.
Detailed business segments for Virax Biolabs Group Ltd aren't currently in our reference dataset.
Sensei's VRAX activity, surfaced from the live alert stream.
Below is the outcome history for VRAX from Sensei's alert feed. Entry, target, and stop levels — plus the chart-level reasoning — are members-only.
- BUYJul 16, 2026Hit+8.96%
- BUYJul 16, 2026Hit+8.08%
- BUYMay 18, 2026Hit+44.19%
- BUYApr 13, 2026Hit+7.80%
- BUYOct 23, 2024Hit+81.00%
- BUYAug 19, 2024Hit+38.46%
- BUYAug 19, 2024Hit+59.29%
- BUYAug 19, 2024Hit+50.00%
- BUYAug 19, 2024Hit+61.29%
- BUYAug 19, 2024Hit+74.76%
Full details unlock inside the app
Common questions about this stock.
What is VRAX?
VRAX is the trading symbol for Virax Biolabs Group Ltd, listed on Nasdaq in the healthcare sector.
What sector is VRAX in?
Virax Biolabs Group Ltd (VRAX) is classified in the healthcare sector — specifically in vitro & in vivo diagnostic substances, based on its SEC SIC classification.
Has Sensei traded VRAX?
Yes — VRAX has appeared in the Sensei alert feed 10 times, including 10 calls that hit target. The "Sensei's calls on VRAX" section above lists the recent history; entry, target, and stop levels are members-only.
Where does VRAX trade?
VRAX trades on Nasdaq.
Is VRAX a stock or an ETF?
VRAX is a publicly-traded common stock, not an ETF.
Trade VRAX alongside Sensei.
Live alerts, a focused community, and the full course library. $60/month. Cancel anytime.